Boston Scientific Taxus Stent News

Boston Scientific Sales Down, Preparing Launch of New Taxus Stent

At a glance:

Boston Scientific reported slower sales of its drug-coated stent this past quarter, due to decreased demand and competition from the other maker of this type of device, Johnson & Johnson. 
 
The FDA has communicated some quality concerns to the company, but they say they are on track for the release of a new version of the Taxus Stent later this year. 
 
A stent is a little bit of wire mesh that is placed inside an artery, to filter out blood clots that can lead to stroke or heart attack.


Boston Scientific net down as heart device sales slow

Reuters - 4/18/2006 2:17 PM

CHICAGO (Reuters) - Boston Scientific Corp., which expects shortly to complete its acquisition of Guidant Corp., said on Tuesday that quarterly earnings fell 7.3 percent on slower sales of devices used to treat clogged heart arteries.
 
But the maker of drug-coated stents -- the small wire mesh devices inserted into coronary arteries to keep blood flowing -- said sales beat Wall Street expectations, and the company's shares rose nearly 2 percent

 
· Read The Full Boston Scientific Taxus Stent Article From Reuters -->

· Read All Boston Scientific Taxus Stent News Stories -->

Comments On Boston Scientific Taxus Stent News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: